Growing overweight and obese population, adoption of sedentary lifestyle globally, high investments in R&D by market players to develop innovative pipeline, greater awareness of weight management programs, and increasing disposable income in developing economies are some of the key factors driving the growth of the obesity drugs market
The effectiveness of semaglutide can vary from person to person
Healthcare providers often recommend a gradual titration schedule to allow the body to acclimate to the drug's effects while minimizing adverse reactions
Diabetes Obes Metab 17:268275
Statistical evaluation of the data was carried out using an unpaired t-test (plasma analytes in study 1, in vitro data), paired t-test (plasma linagliptin), two-way analysis of variance (ANOVA) with Dunnetts post-hoc test (body weight, food intake, OGTT), or KruskalWallis test (plasma analytes in study 2)
For a 200-pound person, that is 30 to 34 pounds